Mitochondrial free [Ca
. The original measurements were made using native aequorin and provided peak [Ca 2 + ] M values of 2-3 μM during histamine stimulation of HeLa cells [2] . Then, when a mutated form of aequorin (with a lower Ca 2 + affinity) that was initially developed to measure [Ca 2 + ] in the endoplasmic reticulum [3] [4] [5] 
EXPERIMENTAL

Cell culture and targeted mutated aequorin expression
HeLa cells were grown in Dulbecco's modified Eagle's medium supplemented with 5 % fetal bovine serum, 100 units/ml penicillin and 100 units/ml streptomycin. The original form of mutated aequorin (119Amut-AEQ) contains an Asp 119 →Ala mutation in the third EF-hand Ca 2 + -binding site of aequorin. The double-mutated aequorin used in the present study was obtained by adding an Asn 28 →Leu mutation in the first EF-hand Ca 2 + -binding site of aequorin. The mutation was performed using the QuikChange ® XL Site-Directed Mutagenesis Kit (Stratagene) with the following oligonucleotide: 5 -TTCAATTTCCTTGATG-TCGACCACCTTGGAAAAATCTCTCTTGACG-3 in a pcDNA 3.1 plasmid containing mitochondrially targeted 119Amut-AEQ (mit-119Amut-AEQ). The mutation also introduces a StyI restriction site which was used for identification. Transfections were carried out using Metafectene (Biontex). • C. Calibration of the luminescence data into [Ca 2 + ] was made using an algorithm adjusted to the calibration, as described previously [7, 14] .
Calibration of mit-28,119mut-AEQ inside mitochondria
HeLa cells expressing mit-28,119mut-AEQ were reconstituted with 2 μM coelenterazine w or coelenterazine i in the presence of 1 μM thapsigargin (to avoid any possible interference from the endoplasmic reticulum Ca 2 + store in the calibration). Then cells were placed in the luminometer, permeabilized as described above and perfused with intracellular medium containing no ATP and no metabolic substrates, 1 mM potassium phosphate, the ionophores ionomycin (1 μM) and FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) ( and behave simply as an aequorin container, freely permeable to Ca 2 + and H + , and ready to perform a calibration in the desired conditions. Cells were then perfused under these conditions with the same intracellular medium containing no EGTA and different unbuffered Ca 2 + concentrations added, from 50 μM to 10 mM. The relationship between the relative luminescence data (luminescence/total residual luminescence or L/L max ) and the corresponding [Ca (n = 3-9). These experimental points were then fitted to the algorithm described previously [7, 12] . The Figure also shows for comparison the calibration curves corresponding to native aequorin reconstituted with wild-type coelenterazine (AEQ-w, curve 1 [12] ) and 119mut-AEQ reconstituted with either wild-type coelenterazine (119mut-AEQ-w, curve 2 [4] ) or coelenterazine n (119mut-AEQ-n, curve 3 [5] ). All of the data represented were obtained at 37 • C.
MATERIALS
Native coelenterazine and coelenterazine i were obtained from Biotium. CGP37157 was from Tocris. Other reagents were from Sigma or Merck.
RESULTS
The native form of aequorin can measure [Ca 2 + ] levels between 100 nM and approximately 5 μM (AEQ reconstituted with wildtype coelenterazine, AEQ-w; Figure 1 , curve 1). It is therefore the preferred form to measure Ca 2 + in the cytosol. To measure [Ca 2 + ] in the endoplasmic reticulum, a mutation was introduced in the third Ca 2 + -binding site (Asp 119 →Ala) [3] . The mutated form reduced the Ca 2 + affinity by approximately 1 order of magnitude when reconstituted with wild-type coelenterazine (119Amut-AEQ-w; Figure 1 , curve 2). That mutation was not enough to measure the high levels of [Ca 2 + ] present in the endoplasmic reticulum, and these measurements required a further reduction in Ca 2 + affinity, obtained by using the semi-synthetic cofactor coelenterazine n to reconstitute the mutated aequorin (119Amut-AEQ-n [5] ; Figure 1, L/L max = − 2 in Figure 1 ). Curve 3 in Figure 1 (119mut-AEQ-n) reaches this level at approxiamtely 200 μM [Ca 2 + ], and therefore the measurement of [Ca 2 + ] values above that is severely limited. This problem was partially overcome by reducing the temperature to 22
• C [15] , a manoeuvre that reduces the affinity of aequorin for Ca 2 + , but even in this case the time limitations persist and many physiological phenomena need to be studied at 37
• C. We have now produced a new aequorin type with lower Ca 2 + affinity by introducing an Asn 28 →Leu mutation in the first Ca 2 + -binding site of aequorin. This second mutation reduced the Ca 2 + affinity of aequorin by a further 1 order of magnitude with respect to the single-mutated protein when reconstituted with wildtype coelenterazine (28,119mut-AEQ-w; Figure 1, curve 4) . The luminescence yield of this protein was similar to that of the mutated or the native proteins, thus allowing the making of measurements with the same quality. With regard to the Ca 2 + affinity of this form, it is only slightly lower than that of 119mut-AEQ-n, but could still be reduced further by reconstituting the protein with a semi-synthetic coelenterazine. In this case, reconstitution of 28,119mut-AEQ with coelenterazine n produced an aequorin form with an extremely low Ca 2 + affinity and poor luminescence yield. However, there is a cofactor with intermediate sensitivity, namely coelenterazine i. Reconstitution of 28,119mut-AEQ with coelenterazine i produced an aequorin form with very good sensitivity in the millimolar range (28,119mut-AEQ-i; Figure 1 , curve 5) and good luminescence yield. This aequorin form will be used throughout the present paper to monitor [Ca 2 + ] M at 37
• C. Substitution of Asn 28 by other amino acids such as isoleucine or histidine also produced active aequorin forms with similar Ca 2 + affinity (results not shown). Figure 2 were much lower in the presence of phosphate. In the presence of 1 mM phosphate, [ Figure 3 show the kinetics of Ca 2 + release from mitochondria in the absence and in the presence of Na + . In the absence of Na + (Figure 3a) , the steady-state [Ca 2 + ] M reached in the presence of the Ca 2 + buffer was higher at all of the phosphate concentrations than in the presence of Na + (Figure 3b (Figure 3b) .
The bottom panels of Figure 3 show the effect of the mitochondrial Na + /Ca 2 + exchanger inhibitor CGP37157. Figure 3( , suggesting that the small rate of increase observed before was due to the balance between two high rates of uptake and release, which nearly compensate. This is confirmed in Figure 3 + from mitochondria at all of the phosphate concentrations, although the kinetics of the effect was different depending on the phosphate concentration of the medium. The release was much faster and complete in the absence of phosphate, even though the starting [Ca 2 + ] M was much higher. In fact, only in the absence of phosphate did [Ca 2 + ] M reach the resting levels after FCCP addition, and was then able to partially recover after removal of the protonophore. In the presence of phosphate, instead, Ca 2 + release was slower, did not reach the original levels and was unable to recover. These effects were also much more evident at 3 mM phosphate than at 1 mM phosphate.
The Ca 2 + release induced by FCCP takes place not only through the Na + /Ca 2 + exchanger, but also through the Ca 2 + uniporter working in reverse. In the right-hand panels of Figure 4 , the experiments were performed in the absence of Na + to block the Na + /Ca 2 + exchanger. As shown in Figure 3 , the steadystate [Ca 2 + ] M reached was higher in all of the cases (note the scale). Then, if FCCP was added in the absence of Ca 2 + (in the presence of EGTA), Ca 2 + release was largely inhibited. However, re-addition of the Ca 2 + buffer paradoxically induced a fast Ca 2 + release, suggesting that Ca 2 + activates the Ca 2 + uniporter and induces Ca 2 + release due to the collapse of the membrane potential. Figures 4(e) and 4(f) show similar experiments, but performed in the presence of 1 or 3 mM phosphate. It is quite interesting to note that the addition of FCCP in Ca 2 + -free medium induced a paradoxical increase in [Ca 2 + ] M , which was not observed in the absence of phosphate. The origin of this increase may rely on the mitochondrial acidification induced by the protonophore FCCP, which could lead to Ca 2 + release from calcium phosphate complexes. In all of the cases, subsequent addition of a Ca 2 + buffer induced a fast Ca 2 + release from the depolarized mitochondria. The MCU has been cloned recently [12, 13] . In the present study we have used shRNA technology to generate HeLa cell clones with silenced MCU, and we have used the new aequorin form to investigate [Ca Figure 3 (e).
Mitochondrial membrane depolarization leads to a fast release of the accumulated Ca 2 + through both the Na + /Ca 2 + exchange system and the Ca 2 + uniporter working in reverse. As we have described previously [22] , this reverse activity of the Ca 2 + uniporter requires not only mitochondrial depolarization, but also the presence of Ca 2 + on the cytosolic side of the mitochondria to activate the release. Therefore if the protonophore is added in the absence of Na + (to block Na + /Ca 2 + exchange) and in EGTA-containing medium, both systems are blocked and the release is very slow. This phenomenon generates the paradoxical effect that perfusion of a Ca 2 + -containing medium under these conditions induces a fast Ca 2 + release from mitochondria. Another paradoxical effect was obtained when FCCP was added in Na + -and Ca 2 + -free medium to mitochondria loaded with Ca 2 + in the presence of phosphate (Figures 4e and 4f ). Under these conditions, the protonophore induced a paradoxical increase in [Ca 2 + ] M , which is probably due to the release of Ca 
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